ArticleOncology letters2017

The combination of anti-HBc and anti-HBs levels is a useful predictor of the development of chemotherapy-induced reactivation in lymphoma patients with resolved HBV infection.

Tokuhiro Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.